Evidence for pleiotropic effects of phosphodiesterase-5 (PDE5) Inhibitors: Emerging concepts in cancer and cardiovascular medicine

Circulation Research

Volumn 108, Issue 9, 2011, Pages 1040-1041

  Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; CYCLIC GMP; DOXORUBICIN; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; SUPEROXIDE DISMUTASE; TADALAFIL;

ANTINEOPLASTIC ACTIVITY; CARDIOVASCULAR SYSTEM; DRUG EFFICACY; DRUG POTENTIATION; ERECTILE DYSFUNCTION; HEART LEFT VENTRICLE FAILURE; NEOPLASM; NONHUMAN; NOTE; OSTEOSARCOMA CELL; PLEIOTROPY; PRIORITY JOURNAL; PROSTATE CANCER; PULMONARY HYPERTENSION; UPREGULATION;

EID: 79955614574     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/RES.0b013e31821d2c31     Document Type: Note

References (9)

1. Boolell M, Allen MG, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res. 1996;8:47-52.
2. Fisher PW, Salloum F, Das A, Hyder H, Kukreja RC. Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity. Circulation. 2005;111:1601-1610. (Pubitemid 40525159)
3. Koka S, Das A, Zhu SG, Durrant D, Xi L, Kukreja RC. Long-acting phosphodiesterase-5 inhibitor tadalafil attenuates doxorubicin-induced cardiomyopathy without interfering with chemotherapeutic effect. J Pharmacol Exp Ther. 2010;334:1023-1030.
4. Das A, Durrant D, Mitchell C, Mayton E, Hoke NN, Salloum F, Park M, Qureshi I, Lee R, Dent P, Kukreja RC. Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction. PNAS. 2010;107:18202-18207.
5. Tsang WP, Chau SP, Kong SP, Fung KP, Kwok TT. Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis. Life Sci. 2003;73:2047-2058. (Pubitemid 36930039)
6. Ignarro LJ, Bush GM, Buga KS, Wood KS, Fukuto JM, Rajfer J. NO and cyclic GMP formation upon electrical field stimulation causes relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun. 1990; 170:843-850. (Pubitemid 20249496)
7. Mehta S. Sildenafil for pulmonary arterial hypertension: exciting, but protection required. Chest 2003;123;989-1992.
8. Okalli R, Salloum F, Hawkins J, Kukreja RC. Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial K(ATP) channels in rabbits. Am J Physiol Heart Circ Physiol. 2002;283: H1263-H1269.
9. Takimoto E, Li M, Ren S, Rodriguez ER, Bedja D, Gabrielson KL, Champion HC, Wang Y, Kass DA. Chronic phosphodiesterase 5a inhibition prevents and reverses cardiac hypertrophy independent of systolic load. Nat Med. 2005;11:214-222. (Pubitemid 40321358)